The agency used data from a national surveillance system to identify cases of ED visits related to unsupervised melatonin ingestion in children 5 years old and younger and estimated that 11,000 such visits occurred in 2019-2022. This accounted for 7% of all ED visits for unsupervised medication exposures in this age group, the CDC said.
Many of the incidents involved gummy products or chewable tablets that may appeal to children, according to the report.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
